Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.55	4.61	56.41	84.83	114.2
Short-Term Investments	119.63	46.49	-	-	-
Cash & Short-Term Investments	140.18	51.1	56.41	84.83	114.2
Cash Growth	174.31%	-9.41%	-33.51%	-25.71%	1199.00%
Other Receivables	-	-	-	-	0.11
Receivables	-	-	-	-	0.11
Prepaid Expenses	2.82	4.94	3.08	3.48	1.29
Other Current Assets	0.73	0.09	0.03	0.03	0.04
Total Current Assets	143.73	56.13	59.52	88.35	115.63
Property, Plant & Equipment	0.93	0.37	0.74	0.77	0.14
Goodwill	-	-	-	48.65	48.65
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39
Other Long-Term Assets	0.36	0.19	0.15	0.4	0.38
Total Assets	177.41	89.07	92.79	170.55	197.19
Accounts Payable	5.83	0.97	2.2	1.81	1.37
Accrued Expenses	5.43	2.55	3.91	2.22	0.97
Current Portion of Leases	0.31	0.38	0.36	0.37	0.14
Total Current Liabilities	11.58	3.9	6.48	4.4	2.48
Long-Term Leases	0.64	-	0.38	0.4	-
Long-Term Deferred Tax Liabilities	2.18	1.75	1.75	1.75	4.11
Other Long-Term Liabilities	44.87	76.21	-	-	-
Total Liabilities	59.27	81.86	8.61	6.55	6.59
Common Stock	0.06	0.02	0.01	0.01	0.02
Additional Paid-In Capital	473.64	326.59	287.03	278.88	270.97
Retained Earnings	-355.59	-319.4	-202.87	-114.9	-80.39
Comprehensive Income & Other	0.03	-	-	-	-
Total Common Equity	118.14	7.21	84.18	164	190.6
Shareholders' Equity	118.14	7.21	84.18	164	190.6
Total Liabilities & Equity	177.41	89.07	92.79	170.55	197.19
Total Debt	0.95	0.38	0.75	0.77	0.14
Net Cash (Debt)	139.22	50.72	55.66	84.06	114.05
Net Cash Growth	174.50%	-8.88%	-33.78%	-26.29%	1247.01%
Net Cash Per Share	2.87	2.06	3.90	5.67	78.58
Filing Date Shares Outstanding	59.88	24.81	13.78	14.31	14.31
Total Common Shares Outstanding	59.79	24.21	13.78	14.31	15.16
Working Capital	132.15	52.23	53.04	83.95	113.15
Book Value Per Share	1.98	0.30	6.11	11.46	12.57
Tangible Book Value	85.75	-25.18	51.8	82.96	109.56
Tangible Book Value Per Share	1.43	-1.04	3.76	5.80	7.23

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q